These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 11846837)

  • 1. Inhibition of tumour invasion and angiogenesis by epigallocatechin gallate (EGCG), a major component of green tea.
    Jung YD; Ellis LM
    Int J Exp Pathol; 2001 Dec; 82(6):309-16. PubMed ID: 11846837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Green tea polyphenols: biology and therapeutic implications in cancer.
    Shankar S; Ganapathy S; Srivastava RK
    Front Biosci; 2007 Sep; 12():4881-99. PubMed ID: 17569617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Green tea polyphenols in the prevention of colon cancer.
    Kumar N; Shibata D; Helm J; Coppola D; Malafa M
    Front Biosci; 2007 Jan; 12():2309-15. PubMed ID: 17127241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reading the tea leaves: anticarcinogenic properties of (-)-epigallocatechin-3-gallate.
    Carlson JR; Bauer BA; Vincent A; Limburg PJ; Wilson T
    Mayo Clin Proc; 2007 Jun; 82(6):725-32. PubMed ID: 17550753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigallocatechin-3-gallate inhibits stem-like inflammatory breast cancer cells.
    Mineva ND; Paulson KE; Naber SP; Yee AS; Sonenshein GE
    PLoS One; 2013; 8(9):e73464. PubMed ID: 24039951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angioprevention': angiogenesis is a common and key target for cancer chemopreventive agents.
    Tosetti F; Ferrari N; De Flora S; Albini A
    FASEB J; 2002 Jan; 16(1):2-14. PubMed ID: 11772931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multistage carcinogenesis process as molecular targets in cancer chemoprevention by epicatechin-3-gallate.
    Pan MH; Chiou YS; Wang YJ; Ho CT; Lin JK
    Food Funct; 2011 Feb; 2(2):101-10. PubMed ID: 21779554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice.
    Wang CC; Xu H; Man GC; Zhang T; Chu KO; Chu CY; Cheng JT; Li G; He YX; Qin L; Lau TS; Kwong J; Chan TH
    Angiogenesis; 2013 Jan; 16(1):59-69. PubMed ID: 22948799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer chemoprevention with green tea catechins by targeting receptor tyrosine kinases.
    Shimizu M; Adachi S; Masuda M; Kozawa O; Moriwaki H
    Mol Nutr Food Res; 2011 Jun; 55(6):832-43. PubMed ID: 21538846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical development plan: tea extracts. Green tea polyphenols. Epigallocatechin gallate.
    J Cell Biochem Suppl; 1996; 26():236-57. PubMed ID: 9154181
    [No Abstract]   [Full Text] [Related]  

  • 11. Anti-invasive effects of green tea polyphenol epigallocatechin-3-gallate (EGCG), a natural inhibitor of metallo and serine proteases.
    Benelli R; Venè R; Bisacchi D; Garbisa S; Albini A
    Biol Chem; 2002 Jan; 383(1):101-5. PubMed ID: 11928805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigallocatechin-3-gallate inhibits the invasion of human oral cancer cells and decreases the productions of matrix metalloproteinases and urokinase-plasminogen activator.
    Ho YC; Yang SF; Peng CY; Chou MY; Chang YC
    J Oral Pathol Med; 2007 Nov; 36(10):588-93. PubMed ID: 17944751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressive Effects of Tea Catechins on Breast Cancer.
    Xiang LP; Wang A; Ye JH; Zheng XQ; Polito CA; Lu JL; Li QS; Liang YR
    Nutrients; 2016 Jul; 8(8):. PubMed ID: 27483305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigallocatechin-3-gallate (EGCG): chemical and biomedical perspectives.
    Nagle DG; Ferreira D; Zhou YD
    Phytochemistry; 2006 Sep; 67(17):1849-55. PubMed ID: 16876833
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor gelatinases and invasion inhibited by the green tea flavanol epigallocatechin-3-gallate.
    Garbisa S; Sartor L; Biggin S; Salvato B; Benelli R; Albini A
    Cancer; 2001 Feb; 91(4):822-32. PubMed ID: 11241252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer prevention by tea: animal studies, molecular mechanisms and human relevance.
    Yang CS; Wang X; Lu G; Picinich SC
    Nat Rev Cancer; 2009 Jun; 9(6):429-39. PubMed ID: 19472429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanistic issues concerning cancer prevention by tea catechins.
    Yang CS; Wang H
    Mol Nutr Food Res; 2011 Jun; 55(6):819-31. PubMed ID: 21538856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of inhibition of tumor angiogenesis and vascular tumor growth by epigallocatechin-3-gallate.
    Fassina G; Venè R; Morini M; Minghelli S; Benelli R; Noonan DM; Albini A
    Clin Cancer Res; 2004 Jul; 10(14):4865-73. PubMed ID: 15269163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of epigallocatechin gallate (EGCG) in the treatment of breast and prostate cancer.
    Stuart EC; Scandlyn MJ; Rosengren RJ
    Life Sci; 2006 Nov; 79(25):2329-36. PubMed ID: 16945390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Multiple actions of EGCG, the main component of green tea].
    L'Allemain G
    Bull Cancer; 1999 Sep; 86(9):721-4. PubMed ID: 10519963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.